Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
163.02
+0.77 (0.47%)
At close: Feb 21, 2025, 4:00 PM
165.15
+2.13 (1.31%)
After-hours: Feb 21, 2025, 7:24 PM EST
CRL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 | Dec '20 Dec 26, 2020 | 2019 - 2015 |
| Revenue | 4,050 | 4,129 | 3,976 | 3,540 | 2,924 | Upgrade
|
| Revenue Growth (YoY) | -1.92% | 3.86% | 12.31% | 21.08% | 11.55% | Upgrade
|
| Cost of Revenue | 2,642 | 2,600 | 2,508 | 2,203 | 1,850 | Upgrade
|
| Gross Profit | 1,408 | 1,529 | 1,468 | 1,337 | 1,074 | Upgrade
|
| Selling, General & Admin | 723.62 | 739.95 | 655.58 | 578.23 | 522.59 | Upgrade
|
| Operating Expenses | 862.09 | 877.39 | 802.15 | 703.08 | 634.47 | Upgrade
|
| Operating Income | 545.86 | 651.79 | 665.51 | 634.39 | 439.08 | Upgrade
|
| Interest Expense | -126.29 | -136.71 | -59.29 | -73.91 | -86.43 | Upgrade
|
| Interest & Investment Income | 8.58 | 5.2 | 0.78 | 0.65 | 0.83 | Upgrade
|
| Earnings From Equity Investments | -12.91 | 97.83 | -26.78 | -30.42 | 100.86 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -46.53 | -31.83 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.03 | -96.68 | -18.4 | 7.79 | 13.09 | Upgrade
|
| EBT Excluding Unusual Items | 417.26 | 521.43 | 515.3 | 506.67 | 467.43 | Upgrade
|
| Merger & Restructuring Charges | -108.49 | -37.68 | -15.71 | -45.96 | -10.01 | Upgrade
|
| Impairment of Goodwill | -215 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.66 | -0.96 | 123.41 | 20 | - | Upgrade
|
| Other Unusual Items | - | 98.5 | - | - | -10.3 | Upgrade
|
| Pretax Income | 93.11 | 581.28 | 622.99 | 480.71 | 447.11 | Upgrade
|
| Income Tax Expense | 67.82 | 100.91 | 130.38 | 81.87 | 81.81 | Upgrade
|
| Earnings From Continuing Operations | 25.29 | 480.37 | 492.61 | 398.84 | 365.31 | Upgrade
|
| Net Income to Company | 25.29 | 480.37 | 492.61 | 398.84 | 365.31 | Upgrade
|
| Minority Interest in Earnings | -3.09 | -5.75 | -6.38 | -7.86 | -1 | Upgrade
|
| Net Income | 22.2 | 474.62 | 486.23 | 390.98 | 364.3 | Upgrade
|
| Preferred Dividends & Other Adjustments | 11.91 | - | - | - | - | Upgrade
|
| Net Income to Common | 10.3 | 474.62 | 486.23 | 390.98 | 364.3 | Upgrade
|
| Net Income Growth | -95.32% | -2.39% | 24.36% | 7.32% | 44.55% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 50 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | 0.34% | 0.29% | -0.24% | 1.61% | 1.85% | Upgrade
|
| EPS (Basic) | 0.20 | 9.27 | 9.57 | 7.77 | 7.35 | Upgrade
|
| EPS (Diluted) | 0.20 | 9.22 | 9.48 | 7.60 | 7.20 | Upgrade
|
| EPS Growth | -97.83% | -2.74% | 24.74% | 5.56% | 42.01% | Upgrade
|
| Free Cash Flow | 501.61 | 365.37 | 294.91 | 532.03 | 380.02 | Upgrade
|
| Free Cash Flow Per Share | 9.72 | 7.10 | 5.75 | 10.35 | 7.51 | Upgrade
|
| Gross Margin | 34.76% | 37.03% | 36.91% | 37.78% | 36.72% | Upgrade
|
| Operating Margin | 13.48% | 15.78% | 16.74% | 17.92% | 15.02% | Upgrade
|
| Profit Margin | 0.25% | 11.49% | 12.23% | 11.04% | 12.46% | Upgrade
|
| Free Cash Flow Margin | 12.39% | 8.85% | 7.42% | 15.03% | 13.00% | Upgrade
|
| EBITDA | 907.6 | 965.92 | 969.38 | 899.93 | 674 | Upgrade
|
| EBITDA Margin | 22.41% | 23.39% | 24.38% | 25.42% | 23.05% | Upgrade
|
| D&A For EBITDA | 361.74 | 314.12 | 303.87 | 265.54 | 234.92 | Upgrade
|
| EBIT | 545.86 | 651.79 | 665.51 | 634.39 | 439.08 | Upgrade
|
| EBIT Margin | 13.48% | 15.78% | 16.74% | 17.92% | 15.02% | Upgrade
|
| Effective Tax Rate | 72.84% | 17.36% | 20.93% | 17.03% | 18.30% | Upgrade
|
| Revenue as Reported | 4,050 | 4,129 | 3,976 | 3,540 | 2,924 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.